BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29034877)

  • 21. Association of NR2E3 but not NRL mutations with retinitis pigmentosa in the Chinese population.
    Yang Y; Zhang X; Chen LJ; Chiang SW; Tam PO; Lai TY; Chan CK; Wang N; Lam DS; Pang CP
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2229-35. PubMed ID: 19933183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD).
    Ahmed E; Sansac C; Fieldes M; Bergougnoux A; Bourguignon C; Mianné J; Arnould C; Vachier I; Assou S; Bourdin A; De Vos J
    Stem Cell Res; 2018 Dec; 33():15-19. PubMed ID: 30296669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene.
    Toustrup LB; Zhou Y; Kvistgaard H; Gregersen N; Rittig S; Aagaard L; Corydon TJ; Luo Y; Christensen JH
    Stem Cell Res; 2017 Mar; 19():37-42. PubMed ID: 28413003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of Small Molecule-Mediated Reprogramming of Rod Photoreceptors to Treat Retinitis Pigmentosa.
    Nakamura PA; Tang S; Shimchuk AA; Ding S; Reh TA
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6407-6415. PubMed ID: 27893103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
    Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of a human iPSC line, INMi005-A, from a patient with non-syndromic USH2A-associated retinitis pigmentosa.
    Sanjurjo-Soriano C; Erkilic N; Vache C; Dubois G; Roux AF; Meunier I; Kalatzis V
    Stem Cell Res; 2022 Apr; 60():102738. PubMed ID: 35248879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of the induced pluripotent stem cell line IOCVi001-A from a patient with the MFRP-related retinitis pigmentosa-nanophthalmos syndrome.
    Mora-Roldan GA; Nava J; Gazarian K; Zenteno JC
    Stem Cell Res; 2024 Mar; 75():103309. PubMed ID: 38217995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of two human iPSC lines from patients with autosomal dominant retinitis pigmentosa (UCLi014-A) and autosomal recessive Leber congenital amaurosis (UCLi015-A), associated with RDH12 variants.
    Sarkar H; Méjécase C; Harding P; Eintracht J; Toualbi L; Cunha DL; Moosajee M
    Stem Cell Res; 2021 Jul; 54():102449. PubMed ID: 34216980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
    Li YP; Liu H; Jin ZB
    Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A).
    Ding Y; Carvalho E; Murphy C; McInerney V; Krawczyk J; O'Brien T; Howard L; Cai L; Shen S
    Stem Cell Res; 2020 Mar; 43():101665. PubMed ID: 31954326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nr2e3 functional domain ablation by CRISPR-Cas9D10A identifies a new isoform and generates retinitis pigmentosa and enhanced S-cone syndrome models.
    Aísa-Marín I; López-Iniesta MJ; Milla S; Lillo J; Navarro G; de la Villa P; Marfany G
    Neurobiol Dis; 2020 Dec; 146():105122. PubMed ID: 33007388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a human iPSC line, INMi003-A, with a missense mutation in CRX associated with autosomal dominant cone-rod dystrophy.
    Erkilic N; Sanjurjo-Soriano C; Diakatou M; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
    Stem Cell Res; 2019 Jul; 38():101478. PubMed ID: 31203166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2.
    Ho MC; Huang CY; Lee JJ; Hsu SH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():38-41. PubMed ID: 29055226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP).
    Schorderet DF; Escher P
    Hum Mutat; 2009 Nov; 30(11):1475-85. PubMed ID: 19718767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
    Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.